2021

• Arndt V, Dahm S, Kraywinkel K (2021): Krebsprävalenz in Deutschland 2017
  Onkologe 2021 (27, 717–723): https://doi.org/10.1007/s00761-021-00988-7.
  mehr

• Sachs B, Dubrall D, Kraywinkel K, et al. (2021): Descriptive analysis of 179 reports of melanoma originating from Germany reported as side effect to an adverse drug reaction database and comparison with melanoma cases contained in German cancer registries
  Clin. Exp. Dermatol. Epub Jan 7 (doi: 10.1111/ced.15091).
  mehr

• Herout R, Baunacke M, Flegar L, Borkowetz A, Reicherz A, Koch R, Kraywinkel K, Thomas C, Groeben C, Huber J (2021): ASO Author Reflections: How Many Centers Do We Need for High-Quality Penile Cancer Surgery in Germany? An Analysis of Total Population Data from 2006 to 2016
  Ann Surg Oncol, 28(13) (9199- 9200): https://doi.org/10.1245/s10434-021-10306-5.
  mehr

• Emrich K, Kraywinkel K (2021): Epidemiologie des Mammakarzinoms von Frauen: Trends in niedrigen Stadien
  Onkologie 27 (12): 1156–1164.
  mehr

• Groeben C, Koch R, Kraywinkel K, Buttmann-Schweiger N, Baunacke M, Borkowetz A, Thomas C, Huber J (2021): Development of Incidence and Surgical Treatment of Penile Cancer in Germany from 2006 to 2016: Potential Implications for Future Management
  Ann Surg Oncol 2021, (doi.org/10.1245/s10434-021-10189-6).
  mehr

• Eberl M, Tanaka LF, Kraywinkel K, Klug SJ (2021): Incidence of smoking-related second primary cancers after lung cancer in Germany: an analysis of nation-wide cancer registry data.
  J. Thorac. Oncol..
  mehr

• Gurung-Schönfeld I, Kraywinkel K (2021): Krebsregistrierung heute: zwischen Epidemiologie, Qualitätssicherung und Forschung
  Epid. Bull. 2021 (4): 3-9.
  Epidemiologisches Bulletin 4/2021 (PDF, 3 MB, Datei ist nicht barrierefrei)